Form 4 for TNGX Tango Therapeutics, Inc.

Accepted 2026-05-01 17:26:21 ET · period of report 2026-04-29 · accession 0001193125-26-201749 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-05-01 17:26	2026-04-29	TNGX	Lee Sung	Dir	A - Grant	$0.00	+12.3K	22.3K	+123%	$0
D	2026-05-01 17:26	2026-04-29	TNGX	Lee Sung	Dir	A - Grant	$0.00	+5,200	5,200	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-04-29	A	A	12,300	$0.00	22,300	D	—	—	(F1) These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments on January 2, 2027, January 2, 2028 and January 2, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The RSUs were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy.
2	Derivative	Stock Option (Right to Buy)	2026-04-29	A	A	5,200	$0.00	5,200	D	$22.06 · — to 2036-04-29	5,200 Common Stock	(F2) This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years commencing on January 2, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The options were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy.